Cancer treatments have advanced significantly in recent decades, but the search continues for therapies that are more effective and less toxic for patients. A class of drugs called PARP inhibitors has emerged as a promising new option, particularly for certain types of breast, ovarian, and other cancers. These inhibitors target DNA repair pathways in cancer cells, helping chemotherapy and...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian